195 related articles for article (PubMed ID: 20210564)
1. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
3. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
Giménez M; Conget I; Nicolau J; Pericot A; Levy I
Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
[TBL] [Abstract][Full Text] [Related]
4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
5. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
9. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
[TBL] [Abstract][Full Text] [Related]
10. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
Monami M; Lamanna C; Marchionni N; Mannucci E
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
Lepore G; Bruttomesso D; Bonomo M; Dodesini AR; Costa S; Meneghini E; Corsi A; Nosari I; Trevisan R
Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235
[TBL] [Abstract][Full Text] [Related]
16. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
18. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
